2-(4-Bromo-2-chlorophenoxy)-N-(4-(N-(4,6-dimethylpyriMidin-2-yl)sulfamoyl)phenylcarbamothioyl)acetamide

587841-73-4

2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide;2-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamideZCL278;ZCL 278;2-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamide;ZCL 2782-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamide;2-(4-Bromo-2-chlorophenoxy)-N-((4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenyl)carbAmothioy

2-(4-Bromo-2-chlorophenoxy)-N-(4-(N-(4,6-dimethylpyriMidin-2-yl)sulfamoyl)phenylcarbamothioyl)acetamide is a selective inhibitor of Cdc42, and effectively inhibits EGF-stimulated Cdc42 activity including microspike formation in 3T3 fibroblasts and neuronal branching in primary neonatal cortical neurons.

584.89

C21H19BrClN5O4S2

200-256-5

Light beige solid

2-8 ℃